APA (7th ed.) Citation

AH, N., & MT, Q. (2026). CRISPR/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational Challenges. Molecular biotechnology, 68(5), 2201. https://doi.org/10.1007/s12033-025-01533-2

Chicago Style (17th ed.) Citation

AH, Nguyen, and Quang MT. "CRISPR/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational Challenges." Molecular Biotechnology 68, no. 5 (2026): 2201. https://doi.org/10.1007/s12033-025-01533-2.

MLA (9th ed.) Citation

AH, Nguyen, and Quang MT. "CRISPR/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational Challenges." Molecular Biotechnology, vol. 68, no. 5, 2026, p. 2201, https://doi.org/10.1007/s12033-025-01533-2.